Determination of topotecan by ELISA

Area of Science:

• Analytical Chemistry
• Pharmacology
• Biochemistry

Background:

• Topotecan is a crucial chemotherapeutic agent.
• Accurate quantification of topotecan is vital for pharmacokinetic and pharmacodynamic studies.
• Existing analytical methods may lack the required sensitivity or throughput.

Purpose of the Study:

• To develop and validate a highly sensitive enzyme-linked immunosorbent assay (ELISA) for topotecan.
• To assess the specificity and comparability of the developed ELISA with existing methods like HPLC.
• To demonstrate the utility of the ELISA in analyzing topotecan levels in biological matrices.

Main Methods:

• Development of a specific anti-topotecan antibody through rabbit immunization.
• Conjugation of topotecan with beta-D-galactosidase using cross-linkers.
• Validation of the ELISA for sensitivity (as low as 80 pg/ml) and specificity.
• Comparison of ELISA results with High-Performance Liquid Chromatography (HPLC) measurements.

Main Results:

• A highly sensitive ELISA for topotecan was successfully developed, measuring down to 80 pg/ml.
• The ELISA demonstrated high specificity for the lactone moiety of topotecan.
• ELISA-derived topotecan concentrations showed good correlation with HPLC values.
• The assay was effectively used to determine topotecan levels in rat blood and urine post-administration.

Conclusions:

• The developed ELISA is a sensitive and specific tool for topotecan determination.
• This assay provides a reliable alternative to HPLC for topotecan quantification.
• The ELISA is suitable for pharmacokinetic and pharmacodynamic studies of topotecan in biological samples.